San Diego, CA, United States of America

Xiaolin Li

This inventor holds 47 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Irm LLC, Novartis Ag, Huawei Technologies Co., Limited. Active years: 2009-2025.

USPTO Granted Patents = 47 

% Patents Active = 66.0

 

 

Average Co-Inventor Count = 5.8

ph-index = 10

Forward Citations = 312(Granted Patents)


Location History:

  • Del Mar, CA (US) (2010 - 2012)
  • Emeryville, CA (US) (2015)
  • San Diego, CA (US) (2009 - 2017)
  • Shenzhen, CN (2015 - 2020)
  • Alameda, CA (US) (2013 - 2021)
  • Dongguan, CN (2015 - 2023)
  • Shanghai, CN (2017 - 2023)

Company Filing History:

goldMedal12 out of 152 
 
Irm LLC
 patents
silverMedal11 out of 3,973 
 
Novartis Ag
 patents
bronzeMedal5 out of 27,557 
 
Huawei Technologies Co., Limited
 patents
44 out of 20 
 
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
 patents
54 out of 26 
 
Yangtze River Pharmaceutical Group Co., Ltd.
 patents
62 out of 121 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents
72 out of 2 
 
Dongguan Jackfruit New Material Technology Co., Ltd.
 patents
82 out of 4 
 
Orphagen Pharmaceuticals
 patents
92 out of 11 
 
Qilu Pharmaceutical Co., Ltd.
 patents
101 out of 209 
 
Baoshan Iron & Steel Co., Ltd.
 patents
111 out of 994 
 
Electric Power Research Institute Incorporated
 patents
121 out of 4 
 
Guangdong Electronics Industry Institute Ltd.
 patents
131 out of 3 
 
Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd.
 patents
141 out of 2 
 
Hamilton
 patents
151 out of 3,122 
 
Tsinghua University
 patents
161 out of 5 
 
Zhongshan Ophthalmic Center, Sun Yat-Sen University
 patents
171 out of 8 
 
Zhuhai United Laboratories Co., Ltd.
 patents
185 out of 834,307 
Other
 patents
where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antiviral Compounds
Kinase Inhibitors
Steroid Derivatives
Cyclic Peptides
SSAO Inhibitor
Lanosterol Prodrug
Pyrimidine Derivatives
Heterocyclic Compounds
Profile Download Method
Film Applicator
Call Record Synchronization
Silicon Steel
47 patents (USPTO):Explore Patents

Title: Xiaolin Li: A Technology Pioneer Shaping the Future of Innovation

Introduction:

Xiaolin Li, a distinguished inventor based in San Diego, CA, is widely recognized for his dedication to innovation and his unwavering pursuit of excellence in the technological realm. With an impressive portfolio of 46 patents to his name, Xiaolin Li continues to inspire and drive forward the future of innovation.

Latest Patents:

Among Xiaolin Li's latest patents is a groundbreaking "Call Record Synchronization Method, Cloud Platform, and Terminal." This innovation revolutionizes the way call records are synchronized and displayed across multiple terminals. By merging call records from different devices, users can effortlessly track call activities and statuses, enhancing overall user experience and efficiency.

Career Highlights:

Throughout his career, Xiaolin Li has made significant contributions to the tech industry through his work with esteemed companies such as Irm LLC and Novartis AG. His expertise and innovative spirit have led to the development of cutting-edge technologies that have reshaped the way we interact with digital platforms.

Collaborations:

Xiaolin Li's collaborative efforts with industry peers, including Valentina Molteni and Juliet Nabakka, have further cemented his reputation as a trailblazer in the field of technology. Together, they have leveraged their diverse skill sets to create impactful solutions that have pushed the boundaries of innovation.

Conclusion:

In conclusion, Xiaolin Li stands as a true pioneer in the world of technology, with a remarkable track record of innovation and excellence. His groundbreaking patents and collaborative endeavors continue to shape the future of innovation, inspiring generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…